Hippocampal Extracellular Matrix Protein Laminin β1 Regulates Neuropathic Pain and Pain-Related Cognitive Impairment
- PMID: 40397355
- DOI: 10.1007/s12264-025-01422-3
Hippocampal Extracellular Matrix Protein Laminin β1 Regulates Neuropathic Pain and Pain-Related Cognitive Impairment
Abstract
Patients suffering from nerve injury often experience exacerbated pain responses and complain of memory deficits. The dorsal hippocampus (dHPC), a well-defined region responsible for learning and memory, displays maladaptive plasticity upon injury, which is assumed to underlie pain hypersensitivity and cognitive deficits. However, much attention has thus far been paid to intracellular mechanisms of plasticity rather than extracellular alterations that might trigger and facilitate intracellular changes. Emerging evidence has shown that nerve injury alters the microarchitecture of the extracellular matrix (ECM) and decreases ECM rigidity in the dHPC. Despite this, it remains elusive which element of the ECM in the dHPC is affected and how it contributes to neuropathic pain and comorbid cognitive deficits. Laminin, a key element of the ECM, consists of α-, β-, and γ-chains and has been implicated in several pathophysiological processes. Here, we showed that peripheral nerve injury downregulates laminin β1 (LAMB1) in the dHPC. Silencing of hippocampal LAMB1 exacerbates pain sensitivity and induces cognitive dysfunction. Further mechanistic analysis revealed that loss of hippocampal LAMB1 causes dysregulated Src/NR2A signaling cascades via interaction with integrin β1, leading to decreased Ca2+ levels in pyramidal neurons, which in turn orchestrates structural and functional plasticity and eventually results in exaggerated pain responses and cognitive deficits. In this study, we shed new light on the functional capability of hippocampal ECM LAMB1 in the modulation of neuropathic pain and comorbid cognitive deficits, and reveal a mechanism that conveys extracellular alterations to intracellular plasticity. Moreover, we identified hippocampal LAMB1/integrin β1 signaling as a potential therapeutic target for the treatment of neuropathic pain and related memory loss.
Keywords: Cognitive impairment; Dorsal hippocampus; Extracellular matrix; Laminin β1; Neuropathic pain.
© 2025. Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences.
Conflict of interest statement
Conflict of interest: The authors declare no conflicts of interest.
Similar articles
-
Extracellular matrix protein laminin β1 regulates pain sensitivity and anxiodepression-like behaviors in mice.J Clin Invest. 2021 Aug 2;131(15):e146323. doi: 10.1172/JCI146323. J Clin Invest. 2021. PMID: 34156983 Free PMC article.
-
Cingulate retinoic acid signaling regulates neuropathic pain and comorbid anxiodepression via extracellular matrix homeostasis.J Clin Invest. 2025 Jul 1;135(17):e190539. doi: 10.1172/JCI190539. eCollection 2025 Sep 2. J Clin Invest. 2025. PMID: 40591414 Free PMC article.
-
cGMP-dependent protein kinase I in the dorsal hippocampus protects against synaptic plasticity and cognitive deficit induced by chronic pain.Pain. 2025 Apr 29. doi: 10.1097/j.pain.0000000000003624. Online ahead of print. Pain. 2025. PMID: 40310865
-
Pathobiology of neuropathic pain.Eur J Pharmacol. 2001 Oct 19;429(1-3):23-37. doi: 10.1016/s0014-2999(01)01303-6. Eur J Pharmacol. 2001. PMID: 11698024 Review.
-
Elucidation of pathophysiology and treatment of neuropathic pain.Cent Nerv Syst Agents Med Chem. 2012 Dec;12(4):304-14. doi: 10.2174/187152412803760645. Cent Nerv Syst Agents Med Chem. 2012. PMID: 23033930 Review.
References
-
- Cohen SP, Vase L, Hooten WM. Chronic pain: An update on burden, best practices, and new advances. Lancet 2021, 397: 2082–2097. - PubMed
-
- Wang TZ, Wang F, Tian ZC, Li ZZ, Liu WN, Ding H, et al. Cingulate cGMP-dependent protein kinase I facilitates chronic pain and pain-related anxiety and depression. Pain 2023, 164: 2447–2462. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous